Skip to main content

SARS 3b Antibody Blocking Peptide

Novus Biologicals, part of Bio-Techne | Catalog # NB100-56746PEP

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NB100-56746PEP

Key Product Details

Conjugate

Unconjugated

Applications

Antibody Competition

Product Specifications

Description

Application Notes

This peptide is useful as a blocking peptide for NB100-56746. For further blocking peptide related protocol, click here.

Specificity

This peptide is specific for NB100-56746 only.

Protein / Peptide Type

Antibody Blocking Peptide

Formulation, Preparation and Storage

NB100-56746PEP
Formulation Peptide dissolved in dH20. Contains no BSA.
Preservative No Preservative
Concentration 1 mg/ml
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Store at -80C. Avoid freeze-thaw cycles.

Background: SARS 3b

Severe Acute Respiratory Syndrome (SARS),an emerging disease characterized by atypical pneumonia, has recently been attributed to anovel coronavirus (SARS-CoV). The protein X2 was one of the nonstructural proteins of SARS-CoV (X1~X5), who's epitopes were defined by parallel comparison of SARS-CoV infected and non-infected human sera with EpitoscreenTM peptide array. The protein X2 of SARS-CoV, also named SARS 3b, shares little homology with proteins of other members of the coronavirus. SARS 3b protein is a putative uncharacterized protein.

Alternate Names

3b, 3b protein, hypothetical protein sars3b, Hypothetical protein X2, Orf3b, ORF4

Additional SARS 3b Products

Product Documents for SARS 3b Antibody Blocking Peptide

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for SARS 3b Antibody Blocking Peptide

This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...